Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- HC Wainwright & Co. analyst Scott Buck initiated coverage on WidePoint Corporation (NYSE:WYY) with a Buy rating and announced a price target of $7. WidePoint shares closed at $3.68 on Wednesday. See how other analysts view this stock.
- UBS analyst David Dai initiated coverage on Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) with a Buy rating and announced a price target of $37. Syndax Pharmaceuticals shares closed at $18.54 on Wednesday. See how other analysts view this stock.
- Jefferies analyst Julien Dumoulin-Smith initiated coverage on Sempra (NYSE:SRE) with a Buy rating and announced a price target of $98. Sempra shares closed at $85.96 on Wednesday. See how other analysts view this stock.
- Leerink Partners analyst David Risinger initiated coverage on Tenax Therapeutics, Inc. (NASDAQ:TENX) with an Outperform rating and announced a price target of $16. Tenax Therapeutics shares closed at $4.32 on Wednesday. See how other analysts view this stock.
- UBS analyst David Dai initiated coverage on CG Oncology, Inc. (NASDAQ:CGON) with a Buy rating and announced a price target of $60. CG Oncology shares closed at $35.61 on Wednesday. See how other analysts view this stock.
Considering buying SRE stock? Here's what analysts think:
Read More:
- Tesla, Dow And 3 Stocks To Watch Heading Into Thursday
